Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Oncology Practice
|
September 14, 2016
Completion of Therapy Talk
Marta Wilejto, Holcombe Grier, Furqan Shaikh
Journal of Neurosurgery. Pediatrics
|
September 24, 2009
Primary pediatric intraspinal sarcomas. Report of 3 cases
Paul Klimo, Patrick J Codd, Holcombe Grier, et al.
Journal of Pediatric and Adolescent Gynecology
|
November 10, 2009
Ovarian tissue autologous transplantation to the upper extremity for girls receiving abdominal/pelvic radiation: 20-year follow-up of reproductive endocrine function
Marc R Laufer, Joseph Upton, Samuel R Schuster, et al.
Journal of Pediatric Hematology/Oncology
|
March 27, 2014
Impaired testicular function after an ifosfamide-containing regimen for pediatric osteosarcoma: a case series and review of the literature
Lisa B Kenney, Eileen Duffey-Lind, David Ebb, et al.
Pediatrics
|
February 5, 2002
Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases
Jennifer J Marler, Joshua B Rubin, Nikolaus S Trede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples
Rui Yang, Rebecca Sowers, BethAnne Mazza, et al.
Pediatric Blood & Cancer
|
April 23, 2014
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study
Sarah Gorlick, Donald A Barkauskas, Mark Krailo, et al.
Plos One
|
July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation
Jason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2012
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group
David Ebb, Paul Meyers, Holcombe Grier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group
Katherine A Janeway, Alexander J Chou, Allen Buxton, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Oncology Practice
|
September 14, 2016
Completion of Therapy Talk
Marta Wilejto, Holcombe Grier, Furqan Shaikh
Journal of Neurosurgery. Pediatrics
|
September 24, 2009
Primary pediatric intraspinal sarcomas. Report of 3 cases
Paul Klimo, Patrick J Codd, Holcombe Grier, et al.
Journal of Pediatric and Adolescent Gynecology
|
November 10, 2009
Ovarian tissue autologous transplantation to the upper extremity for girls receiving abdominal/pelvic radiation: 20-year follow-up of reproductive endocrine function
Marc R Laufer, Joseph Upton, Samuel R Schuster, et al.
Journal of Pediatric Hematology/Oncology
|
March 27, 2014
Impaired testicular function after an ifosfamide-containing regimen for pediatric osteosarcoma: a case series and review of the literature
Lisa B Kenney, Eileen Duffey-Lind, David Ebb, et al.
Pediatrics
|
February 5, 2002
Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases
Jennifer J Marler, Joshua B Rubin, Nikolaus S Trede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples
Rui Yang, Rebecca Sowers, BethAnne Mazza, et al.
Pediatric Blood & Cancer
|
April 23, 2014
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study
Sarah Gorlick, Donald A Barkauskas, Mark Krailo, et al.
Plos One
|
July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation
Jason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2012
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group
David Ebb, Paul Meyers, Holcombe Grier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group
Katherine A Janeway, Alexander J Chou, Allen Buxton, et al.
Page
of 2